This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vicca, J.
Right arrow Articles by Haesebrouck, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vicca, J.
Right arrow Articles by Haesebrouck, F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2004, p. 4470-4472, Vol. 48, No. 11
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.11.4470-4472.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

In Vitro Susceptibilities of Mycoplasma hyopneumoniae Field Isolates

J. Vicca,1,2* T. Stakenborg,3 D. Maes,1 P. Butaye,3 J. Peeters,3 A. de Kruif,1 and F. Haesebrouck2

Department of Reproduction, Obstetrics and Herd Health,1 Department of Bacteriology, Pathology and Poultry Diseases, Faculty of Veterinary Medicine, Ghent University, Merelbeke,2 CODA-CERVA, Veterinary and Agrochemical Research Centre, Brussels, Belgium3

Received 31 March 2004/ Returned for modification 27 May 2004/ Accepted 27 July 2004

The in vitro susceptibilities of 21 Mycoplasma hyopneumoniae field isolates were determined using a broth microdilution technique. One isolate showed acquired resistance to lincomycin, tilmicosin, and tylosin, while five isolates were resistant to flumequine and enrofloxacin. Acquired resistance against these antimicrobials in M. hyopneumoniae field isolates was not reported previously.


* Corresponding author. Mailing address: Department of Reproduction, Obstetrics and Herd Health, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820 Merelbeke, Belgium. Phone: 32 (0)9 264 75 49. Fax: 32 (0)9 264 77 98. E-mail: Jo.Vicca{at}UGent.be.


Antimicrobial Agents and Chemotherapy, November 2004, p. 4470-4472, Vol. 48, No. 11
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.11.4470-4472.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Antunes, N. T., Tavio, M. M., Mercier, P., Ayling, R. D., Al-Momani, W., Assuncao, P., Rosales, R. S., Poveda, J. B. (2007). In Vitro Susceptibilities of Mycoplasma putrefaciens Field Isolates. Antimicrob. Agents Chemother. 51: 3452-3454 [Abstract] [Full Text]  
  • Assuncao, P., Antunes, N. T., Rosales, R. S., Poveda, C., Poveda, J. B., Davey, H. M. (2006). Flow Cytometric Determination of the Effects of Antibacterial Agents on Mycoplasma agalactiae, Mycoplasma putrefaciens, Mycoplasma capricolum subsp. capricolum, and Mycoplasma mycoides subsp. mycoides Large Colony Type.. Antimicrob. Agents Chemother. 50: 2845-2849 [Abstract] [Full Text]